Comparative Study Of New Drug Application Procedure In Us, Eu And India
Developing a new drug requires great amount of research work in chemistry, manufacturing, controls, preclinical science and clinical trials. Drug reviewers in regulatory agencies around the world bear the responsibility of evaluating whether the research data support the safety, effectiveness and quality control of a new drug product to serve the public health. Every country has its own regulatory authority, which is responsible to enforce the rules and regulations and issue the guidelines to regulate the marketing of the drugs. This article focuses on drug approval process in different countries like USA, Europe and India.
Authors
- Sumreen Begum (ORCID: https://orcid.org/0000-0002-2236-1726)
- B. Shivasai
- S. Sunayana
Institutions
- P.V. Narsimha Rao Telangana Veterinary University (IN)
Publication Details
- Journal
- International Journal of Allied Medical Sciences and Clinical Research
- Published
- 2024-11-28
- DOI
- https://doi.org/10.61096/ijamscr.v12.iss4.2024.585-595
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article
- Field-Weighted Citation Impact
- 0.00